Recent molecular studies have reported that aberrant tumor glycolysis regulates the CEBPB signaling axis and modulates the tumor-associated Myeloid-Derived Suppressor Cells through interconnected autophagy and pyroptosis pathways, thereby maintaining the immunosuppressive phenotype within the TME (34). This evidence concerns the gene CEBPB and neoplasm.